Hamada K, Nagumo Y, Kandori S, Isoda B, Suzuki S, Sano K
Cancer Sci. 2024; 116(2):381-392.
PMID: 39528232
PMC: 11786306.
DOI: 10.1111/cas.16393.
Liu X, Shen L, Wang H
J Cancer. 2024; 15(10):2981-2993.
PMID: 38706911
PMC: 11064252.
DOI: 10.7150/jca.89970.
Munoz-Galvan S, Verdugo-Sivianes E, Santos-Pereira J, Estevez-Garcia P, Carnero A
J Exp Clin Cancer Res. 2024; 43(1):57.
PMID: 38403587
PMC: 10895852.
DOI: 10.1186/s13046-024-02988-y.
Lo Presti C, Yamaryo-Botte Y, Mondet J, Berthier S, Nutiu D, Botte C
Int J Mol Sci. 2023; 24(6).
PMID: 36983080
PMC: 10054724.
DOI: 10.3390/ijms24065988.
Panuzzo C, Pironi L, Maglione A, Rocco S, Stanga S, Riganti C
Int J Mol Sci. 2023; 24(2).
PMID: 36674750
PMC: 9865638.
DOI: 10.3390/ijms24021234.
p73α1, an Isoform of the p73 Tumor Suppressor, Modulates Lipid Metabolism and Cancer Cell Growth via Stearoyl-CoA Desaturase-1.
Rabow Z, Laubach K, Kong X, Shen T, Mohibi S, Zhang J
Cells. 2022; 11(16).
PMID: 36010592
PMC: 9406568.
DOI: 10.3390/cells11162516.
Upregulated phospholipase D2 expression and activity is related to the metastatic properties of melanoma.
Perez-Valle A, Ochoa B, Shah K, Barreda-Gomez G, Astigarraga E, Boyano M
Oncol Lett. 2022; 23(5):140.
PMID: 35340556
PMC: 8931840.
DOI: 10.3892/ol.2022.13260.
Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells.
de Freitas Saito R, Andrade L, Bustos S, Chammas R
Front Immunol. 2022; 13:768606.
PMID: 35250970
PMC: 8889569.
DOI: 10.3389/fimmu.2022.768606.
Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer.
Chang Y, Chang P, Li C, Chan M, Lee Y, Chen M
Front Oncol. 2022; 11:811635.
PMID: 35127525
PMC: 8813753.
DOI: 10.3389/fonc.2021.811635.
mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme.
Ramaiah M, Kumar K
Mol Biol Rep. 2021; 48(5):4813-4835.
PMID: 34132942
DOI: 10.1007/s11033-021-06462-2.
Phospholipase Signaling in Breast Cancer.
Lee Y, Shin K, Jang H, Noh D, Ryu S, Suh P
Adv Exp Med Biol. 2021; 1187:23-52.
PMID: 33983572
DOI: 10.1007/978-981-32-9620-6_2.
Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche.
Han P, Cao P, Hu S, Kong K, Deng Y, Zhao B
Cancer Manag Res. 2020; 12:5857-5879.
PMID: 32765088
PMC: 7371556.
DOI: 10.2147/CMAR.S258215.
Hypoxia induced changes in miRNAs and their target mRNAs in extracellular vesicles of esophageal squamous cancer cells.
Chen F, Chu L, Li J, Shi Y, Xu B, Gu J
Thorac Cancer. 2020; 11(3):570-580.
PMID: 31922357
PMC: 7049507.
DOI: 10.1111/1759-7714.13295.
Mammalian phospholipase D: Function, and therapeutics.
McDermott M, Wang Y, Wakelam M, Bankaitis V
Prog Lipid Res. 2019; 78:101018.
PMID: 31830503
PMC: 7233427.
DOI: 10.1016/j.plipres.2019.101018.
Phospholipase D2 in prostate cancer: protein expression changes with Gleason score.
Noble A, Hogg K, Suman R, Berney D, Bourgoin S, Maitland N
Br J Cancer. 2019; 121(12):1016-1026.
PMID: 31673104
PMC: 6964697.
DOI: 10.1038/s41416-019-0610-7.
BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis.
Barton M, Santucci-Pereira J, Vaccaro O, Nguyen T, Su Y, Russo J
BMC Cancer. 2019; 19(1):994.
PMID: 31646972
PMC: 6813071.
DOI: 10.1186/s12885-019-6179-y.
Cytotoxic Potential of the Coelomic Fluid Extracted from the Sea Cucumber against Triple-Negative MDA-MB231 Breast Cancer Cells.
Luparello C, Ragona D, Asaro D, Lazzara V, Affranchi F, Celi M
Biology (Basel). 2019; 8(4).
PMID: 31600896
PMC: 6955747.
DOI: 10.3390/biology8040076.
Role of phospholipase D in migration and invasion induced by linoleic acid in breast cancer cells.
Diaz-Aragon R, Ramirez-Ricardo J, Cortes-Reynosa P, Simoni-Nieves A, Gomez-Quiroz L, Salazar E
Mol Cell Biochem. 2019; 457(1-2):119-132.
PMID: 30877512
DOI: 10.1007/s11010-019-03517-8.
Cytotoxic Activity of the Histone Deacetylase 3-Selective Inhibitor Pojamide on MDA-MB-231 Triple-Negative Breast Cancer Cells.
Luparello C, Asaro D, Cruciata I, Hassell-Hart S, Sansook S, Spencer J
Int J Mol Sci. 2019; 20(4).
PMID: 30781804
PMC: 6412298.
DOI: 10.3390/ijms20040804.
Three-Dimensional Mass Spectrometry Imaging Identifies Lipid Markers of Medulloblastoma Metastasis.
Paine M, Liu J, Huang D, Ellis S, Trede D, Kobarg J
Sci Rep. 2019; 9(1):2205.
PMID: 30778099
PMC: 6379434.
DOI: 10.1038/s41598-018-38257-0.